SFlt-1/PlGF Ratio Is Not a Good Predictor of Severe Covid-19 nor of Adverse Outcome in Pregnant Women with Sars-CoV-2 Infection—A Case-Control Study

Datos Bibliográficos

ID15499136
AutoresEwa Malicka (Postgraduate School of Molecular Medicine), Iwona Szymusik (0000-0001-8106-5428, Postgraduate School of Molecular Medicine), Beata Rebizant (0000-0002-1696-7561, Postgraduate School of Molecular Medicine), Filip Dąbrowski (0000-0002-8557-4091, Postgraduate School of Molecular Medicine), Robert Brawura-Biskupski-Samaha (0000-0001-5784-873X, Postgraduate School of Molecular Medicine), Katarzyna Kosińska–Kaczyńska (0000-0001-5461-273X, Postgraduate School of Molecular Medicine, autor de correspondencia)
Año2022
Volumen19
Número22
Páginas15054-15054
Fecha de publicación2022-11-16
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaInternational Journal of Environmental Research and Public Health (JOURNAL)
Identificadores de la revistaISSN: 1661-7827 • E-ISSN: 1660-4601
EditorialMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/ijerph192215054
PMID36429772
OpenAlexW4309313248
IdiomaEN
Referencias citadas21

sFlt-1 and sFlt-1/PlGF ratio are related to SARS-CoV-2 infection and the severity of COVID-19 during pregnancy. However, sFlt-1/PlGF ratio is not a good predictor of severe COVID-19 or adverse outcome

Adverse effect · Case-control study · Coronavirus disease 2019 (COVID-19 · Disease · Infectious disease (medical specialty · Intensive care unit · Preeclampsia · Pregnancy · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 · Severity of illness · COVID-19 Impact on Reproduction · Medicine · Pregnancy and preeclampsia studies · Reproductive System and Pregnancy · Internal Medicine

Herramientas

Abrir DOIOpen Access